Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chang

Showing results (401-410 of 424) with videos related to

Pageof 43
Sort By:
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2022
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cellsBarbra J Sasu, Gregory J Opiteck, Suhasni Gopalakrishnan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 29, 2010
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in miceTarl W Prow, Xianfeng Chen, Natalie A Prow, et al.
Ecology|May 27, 2020
Full lifetime perspectives on the costs and benefits of lay-date variation in tree swallowsDavid W Winkler, Kelly K Hallinger, Teresa M Pegan, et al.
British Journal of Cancer|September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
British Journal of Cancer|October 12, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas J A Adamson, et al.
Cell Metabolism|March 5, 2019
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic CancerChristopher J Halbrook, Corbin Pontious, Ilya Kovalenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring SideroblastsGabriele Todisco, Maria Creignou, Elsa Bernard, et al.
EMBO Molecular Medicine|June 17, 2015
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyBryan W Miller, Jennifer P Morton, Mark Pinese, et al.
Ecology|February 6, 2026
Comparing tree swallow dispersal strategies in a continuous mainland environmentKelly K Hallinger, Teresa M Pegan, Michael J Andersen, et al.
Pageof 43

Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2022
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cellsBarbra J Sasu, Gregory J Opiteck, Suhasni Gopalakrishnan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 29, 2010
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in miceTarl W Prow, Xianfeng Chen, Natalie A Prow, et al.
Ecology|May 27, 2020
Full lifetime perspectives on the costs and benefits of lay-date variation in tree swallowsDavid W Winkler, Kelly K Hallinger, Teresa M Pegan, et al.
British Journal of Cancer|September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
British Journal of Cancer|October 12, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas J A Adamson, et al.
Cell Metabolism|March 5, 2019
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic CancerChristopher J Halbrook, Corbin Pontious, Ilya Kovalenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring SideroblastsGabriele Todisco, Maria Creignou, Elsa Bernard, et al.
EMBO Molecular Medicine|June 17, 2015
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyBryan W Miller, Jennifer P Morton, Mark Pinese, et al.
Ecology|February 6, 2026
Comparing tree swallow dispersal strategies in a continuous mainland environmentKelly K Hallinger, Teresa M Pegan, Michael J Andersen, et al.
Pageof 43